Large-Scale Applied Research Project (LSARP) Competition: Genomics and Precision HealthPublished: November 14th 2016
Genome Canada has announced its Large-Scale Applied Research Project Competition in Precision Health, which is expected to be launched in January 2017. This highly competitive funding opportunity is aimed at supporting projects that demonstrate how genomics-based research can improve health care, contribute to a more evidence-based approach to health, and enhance the cost-effectiveness of the health care system.
In keeping with Genome Canada’s mandate to invest in large-scale research, projects can range in budget from approximately $2 million to $10 million, over a term of up to four years. Successful projects in recent competitions have most often been pan-Canadian in scope and team composition. Genome Canada will provide a portion of funding for each project with the remainder to be obtained through co-funding from other sources. The exact co-funding ratio will be available at the time of launch.
Applicants will be required to apply for funding through their regional Genome Centre. The application process will be comprised of three steps: Registration, Pre-Application and Full Application. Based on a January 2017 Competition launch, the deadline for Registrations is expected to be in March, 2017.
Even though the competition doesn’t launch until the new year, Genome Atlantic wants to ensure researchers have the resources and guidance to prepare a competitive application. We plan to engage and support local teams by offering help with proposal development all the way through to hiring strategic consultants and expert reviewers.
In order to ensure that Genome Atlantic can provide teams with access to this support, we are asking interested researchers to fill out an early Expression of Interest form prior to December 12, 2016. This form is available via the following link: LSARP early Expression of Interest form.
For more information about the opportunity or process, please contact Kristin Tweel or Britta Fiander.